Cargando…

Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases

BACKGROUND: Three genes clustered together on chromosome 12 comprise a group of hydroxycarboxylic acid receptors (HCARs): HCAR1, HCAR2, and HCAR3. These paralogous genes encode different G-protein coupled receptors responsible for detecting glycolytic metabolites and controlling fatty acid oxidation...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuire Sams, Cierla, Shepp, Kasey, Pugh, Jada, Bishop, Madison R., Merner, Nancy D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638184/
https://www.ncbi.nlm.nih.gov/pubmed/34852802
http://dx.doi.org/10.1186/s12920-021-01126-3
_version_ 1784608900434100224
author McGuire Sams, Cierla
Shepp, Kasey
Pugh, Jada
Bishop, Madison R.
Merner, Nancy D.
author_facet McGuire Sams, Cierla
Shepp, Kasey
Pugh, Jada
Bishop, Madison R.
Merner, Nancy D.
author_sort McGuire Sams, Cierla
collection PubMed
description BACKGROUND: Three genes clustered together on chromosome 12 comprise a group of hydroxycarboxylic acid receptors (HCARs): HCAR1, HCAR2, and HCAR3. These paralogous genes encode different G-protein coupled receptors responsible for detecting glycolytic metabolites and controlling fatty acid oxidation. Though better known for regulating lipid metabolism in adipocytes, more recently, HCARs have been functionally associated with breast cancer proliferation/survival; HCAR2 has been described as a tumor suppressor and HCAR1 and HCAR3 as oncogenes. Thus, we sought to identify germline variants in HCAR1, HCAR2, and HCAR3 that could potentially be associated with breast cancer risk. METHODS: Two different cohorts of breast cancer cases were investigated, the Alabama Hereditary Cancer Cohort and The Cancer Genome Atlas, which were analyzed through nested PCRs/Sanger sequencing and whole-exome sequencing, respectively. All datasets were screened for rare, non-synonymous coding variants. RESULTS: Variants were identified in both breast cancer cohorts, some of which appeared to be associated with breast cancer BC risk, including HCAR1 c.58C > G (p.P20A), HCAR2 c.424C > T (p.R142W), HCAR2 c.517_518delinsAC (p.G173T), HCAR2 c.1036A > G (p.M346V), HCAR2 c.1086_1090del (p.P363Nfs*26), HCAR3 c.560G > A (p.R187Q), and HCAR3 c.1117delC (p.Q373Kfs*82). Additionally, HCAR2 c.515C > T (p.S172L), a previously identified loss-of-function variant, was identified. CONCLUSIONS: Due to the important role of HCARs in breast cancer, it is vital to understand how these genetic variants play a role in breast cancer risk and proliferation and their consequences on treatment strategies. Additional studies will be needed to validate these findings. Nevertheless, the identification of these potentially pathogenic variants supports the need to investigate their functional consequences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-021-01126-3.
format Online
Article
Text
id pubmed-8638184
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86381842021-12-02 Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases McGuire Sams, Cierla Shepp, Kasey Pugh, Jada Bishop, Madison R. Merner, Nancy D. BMC Med Genomics Research Article BACKGROUND: Three genes clustered together on chromosome 12 comprise a group of hydroxycarboxylic acid receptors (HCARs): HCAR1, HCAR2, and HCAR3. These paralogous genes encode different G-protein coupled receptors responsible for detecting glycolytic metabolites and controlling fatty acid oxidation. Though better known for regulating lipid metabolism in adipocytes, more recently, HCARs have been functionally associated with breast cancer proliferation/survival; HCAR2 has been described as a tumor suppressor and HCAR1 and HCAR3 as oncogenes. Thus, we sought to identify germline variants in HCAR1, HCAR2, and HCAR3 that could potentially be associated with breast cancer risk. METHODS: Two different cohorts of breast cancer cases were investigated, the Alabama Hereditary Cancer Cohort and The Cancer Genome Atlas, which were analyzed through nested PCRs/Sanger sequencing and whole-exome sequencing, respectively. All datasets were screened for rare, non-synonymous coding variants. RESULTS: Variants were identified in both breast cancer cohorts, some of which appeared to be associated with breast cancer BC risk, including HCAR1 c.58C > G (p.P20A), HCAR2 c.424C > T (p.R142W), HCAR2 c.517_518delinsAC (p.G173T), HCAR2 c.1036A > G (p.M346V), HCAR2 c.1086_1090del (p.P363Nfs*26), HCAR3 c.560G > A (p.R187Q), and HCAR3 c.1117delC (p.Q373Kfs*82). Additionally, HCAR2 c.515C > T (p.S172L), a previously identified loss-of-function variant, was identified. CONCLUSIONS: Due to the important role of HCARs in breast cancer, it is vital to understand how these genetic variants play a role in breast cancer risk and proliferation and their consequences on treatment strategies. Additional studies will be needed to validate these findings. Nevertheless, the identification of these potentially pathogenic variants supports the need to investigate their functional consequences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-021-01126-3. BioMed Central 2021-12-01 /pmc/articles/PMC8638184/ /pubmed/34852802 http://dx.doi.org/10.1186/s12920-021-01126-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
McGuire Sams, Cierla
Shepp, Kasey
Pugh, Jada
Bishop, Madison R.
Merner, Nancy D.
Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases
title Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases
title_full Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases
title_fullStr Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases
title_full_unstemmed Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases
title_short Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases
title_sort rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638184/
https://www.ncbi.nlm.nih.gov/pubmed/34852802
http://dx.doi.org/10.1186/s12920-021-01126-3
work_keys_str_mv AT mcguiresamscierla rareandpotentiallypathogenicvariantsinhydroxycarboxylicacidreceptorgenesidentifiedinbreastcancercases
AT sheppkasey rareandpotentiallypathogenicvariantsinhydroxycarboxylicacidreceptorgenesidentifiedinbreastcancercases
AT pughjada rareandpotentiallypathogenicvariantsinhydroxycarboxylicacidreceptorgenesidentifiedinbreastcancercases
AT bishopmadisonr rareandpotentiallypathogenicvariantsinhydroxycarboxylicacidreceptorgenesidentifiedinbreastcancercases
AT mernernancyd rareandpotentiallypathogenicvariantsinhydroxycarboxylicacidreceptorgenesidentifiedinbreastcancercases